Erzincan Binali Yıldırım ÜniversitesiErzincan Binali Yıldırım ÜniversitesiAçık Erişim Arşivi · RDL Open

Correction: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (BMC Cancer, (2024), 24, 1, (16), 10.1186/s12885-023-11783-5)

CorrectionAçık Erişim

Özet

Following publication of the original article [1], the authors reported an error in the affiliations of authors Başak Oyan, Özlem Sönmez, Leyla Özer, Ali Arıcan, Özlem Er and Mustafa Bozkurt. These authors are all affiliated to institution 2. The original article [1] has been corrected. © 2024, The Author(s).

Anahtar Kelimeler

fluorouracilregorafenibarticlecolon cancerdrug combinationmalignant neoplasmmetastatic colorectal cancertherapythird-line treatmentclinical articledrug therapyerratumhumanintravenous drug administrationmale
RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/11082Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1186/s12885-024-11863-0Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorTaşçı, Elif Şenocak
dc.contributor.authorOyan, Başak
dc.contributor.authorSönmez, Özlem
dc.contributor.authorMutlu, Arda Ulaş
dc.contributor.authorAtcı, Muhammed Mustafa
dc.contributor.authorSakin, Abdullah
dc.contributor.authorÖner, İrem
dc.contributor.authorÇınkır, Havva Yeşil
dc.contributor.authorEryılmaz, Melek Karakurt
dc.contributor.authorÇağlayan, Dilek
dc.contributor.authorBalçık, Onur Yazdan
dc.contributor.authorPaksoy, Nail
dc.contributor.authorKarabulut, Senem
dc.contributor.authorSalim, Derya Kıvrak
dc.contributor.authorBilir, Cemil
dc.contributor.authorÖzen, Miraç
dc.contributor.authorÖzçelik, Melike
dc.contributor.authorArıcan, Ali
dc.contributor.authorAkagündüz, Baran
dc.contributor.authorİnal, Ali
dc.contributor.authorAydın, Dinçer
dc.contributor.authorÖzer, Leyla
dc.contributor.authorGülmez, Ahmet
dc.contributor.authorTurhal, Nazım Serdar
dc.contributor.authorEsen, Selin Aktürk
dc.contributor.authorAlgın, Efnan
dc.contributor.authorAkbaş, Sinem
dc.contributor.authorİriağaç, Yakup
dc.contributor.authorŞakalar, Teoman
dc.contributor.authorÜnal, Çağlar
dc.contributor.authorEr, Özlem
dc.contributor.authorSeçmeler, Şaban
dc.contributor.authorBozkurt, Mustafa
dc.date.accessioned2026-10-18T20:26:11.168898912Z
dc.date.available2026-10-18T20:26:11.168898912Z
dc.date.issued2024
dc.description.abstractFollowing publication of the original article [1], the authors reported an error in the affiliations of authors Başak Oyan, Özlem Sönmez, Leyla Özer, Ali Arıcan, Özlem Er and Mustafa Bozkurt. These authors are all affiliated to institution 2. The original article [1] has been corrected. © 2024, The Author(s).
dc.identifier.doi10.1186/s12885-024-11863-0
dc.identifier.issn1471-2407
dc.identifier.issue1
dc.identifier.pmid38262962
dc.identifier.scopus2-s2.0-85182828807
dc.identifier.startpage114
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/11082
dc.identifier.volume24
dc.language.isoen
dc.publisherBioMed Central Ltd
dc.relation.ispartofBMC Cancer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectfluorouracil
dc.subjectregorafenib
dc.subjectarticle
dc.subjectcolon cancer
dc.subjectdrug combination
dc.subjectmalignant neoplasm
dc.subjectmetastatic colorectal cancer
dc.subjecttherapy
dc.subjectthird-line treatment
dc.subjectclinical article
dc.subjectdrug therapy
dc.subjecterratum
dc.subjecthuman
dc.subjectintravenous drug administration
dc.subjectmale
dc.titleCorrection: Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (BMC Cancer, (2024), 24, 1, (16), 10.1186/s12885-023-11783-5)
dc.typeCorrection
dspace.entity.typePublication
rdl.citation.scopus1
rdl.oa.statusgold
rdl.source.indexSCOPUS